Too many middlemen disconnects you from patients.

See How Close
Lost in Transition Telephones
Lost in Transition

Treating rare disease shouldn’t be like a bad game of telephone, with each step generating chaos and confusion. Patient adherence suffers, quality of care diminishes, manufacturers miss out on vital feedback and cost goes up. But imagine if you could cut past all that. We did.

Learn More

DOHMEN NEWS

Learn what's happening in the world of Dohmen and our clients
August 02, 2016

Dohmen appoints Michael Kurland, Vice President, Market Access and Government Programs, DLSS Financial Services

Dohmen recently welcomed Michael Kurland as Vice President of Market Access and Government Programs, Financial Services for Dohmen Life Science Services. With nearly 20 years of experience in the pharmaceutical and biotech industries, Kurland will help clients navigate the complex public and private payer marketplace.
learn more
July 19, 2016

Making the case for an integrated specialty care model

Ready for the understatement of the year? Our industry is in a sea of change. We feel it. Our clients feel it. Their patients feel it. That’s why it came as no surprise when Marie Lamont, our President of Patient Services at Dohmen Life Science Services, was asked to present at the World Congress 3rd Annual Summit on 2016 Specialty Network Design and Channel Optimization.
learn more
July 13, 2016

Pharmacy students selected for the $10,000 Dohmen Life Science Services scholarship

Two student pharmacists at the University of California, San Francisco School of Pharmacy will receive the Dohmen Life Science Services $10,000 Scholarship. Kendra Radtke, Class of 2018, and Gabriel Wong, Class of 2017, were selected for their academic excellence, entrepreneurial spirit and desire to serve the life science industry - traits reflecting the achievements of Dr. Sally Van Doren, PharmD.
learn more
July 11, 2016

Dohmen appoints James Beckom, Vice President, Financial Planning, DLSS Compliance Services

Dohmen recently welcomed James Beckom as Vice President, Financial Planning and Analysis, Compliance Services for Dohmen Life Science Services. Beckom brings more than two decades of experience at global, multi-billion dollar biotech companies, including Abbott Labs, Hospira, Lundbeck and AbbVie.
learn more
July 01, 2016

Dohmen welcomes Pat Coles, Vice President, DLSS Corporate Compliance

Dohmen recently announced the appointment of Pat Coles, vice president of Corporate Quality for Dohmen Life Science Services. Coles joins DLSS with more than 25 years of global quality and compliance expertise in the pharmaceutical and medical device industries.
learn more
June 23, 2016

Dohmen proudly sponsors the 25th Alpha-1 National Education Conference, June 24-26

Dohmen Life Science Services (DLSS) is proud to be the lead sponsor of the 25th Alpha-1 National Education Conference in Miami, FL. The DLSS team will join more than 600 Alpha-1 patients, family members, caregivers and supporters at the event, hosted by the Alpha-1 Foundation.
learn more
June 01, 2016

Dohmen showcases orphan drug and rare disease expertise at BIO International Convention

Dohmen Life Science Services experts will join more than 15,000 biotech and pharma leaders at the BIO International Convention in San Francisco, CA, June 7-9.
learn more
May 11, 2016

Colorado BioScience Association taps Dohmen’s Terry Dagnon to join Board of Directors

The Colorado BioScience Association (CBSA) has asked Terry Dagnon, M.S., DLSS Senior Vice President of Operations, to join its Board of Directors.
learn more